Magrolimab-induced transient decrease of red blood cells (RBCs) and hemoglobin corroborates clinical findings

Anti-CD47 Magrolimab-induced anti-tumor activity

hCD47 and hSIRPα expression pattern in genO‑hCD47/hSIRPα mice recapitulates mCD47 and mSIRPα in wild-type mice
Splenocytes from genO‑hCD47/hSIRPα. Expression of mCD47 and mSIRPα (upper panel), and hCD47 and hSIRPα (lower panel) were evaluated on splenic dendritic cells (DC) (viable, CD3-CD19-CD11b+CD11c+).
